Traffic Roots Audience Pixel

Post categorized under: Cannabis


With the Cannabis industry increasingly competitive for labs, growers and processors, new innovation and improved practices can be the difference in delivering ROI and outlasting competitors. PathogenDx delivers a unique Microarray technology that dramatically reduces testing turnaround time, adds flexibility to how and what can be tested for, and increases efficiencies for a cleaner Cannabis future. Here are the issues Cannabis faces now, with insights to help us all compete and win.

  • Has the CBD Regulatory Landscape Changed?

    The regulation of CBD in the United States can be described as makeshift, and that is being generous. On a federal level, Cannabis in all shapes and forms is a Schedule I controlled substance, but no federal agency has taken charge of regulating CBD products, leaving decisions up to the individual states.

    Read more »

  • Florida Marijuana Testing Labs Under Fire as Industry Tackles Potency Problem

    The issues of inflated THC potency results and lab shopping are plaguing states with large Cannabis industries. The situation has created a public mistrust of marijuana testing-labs as well as a trend among marijuana businesses to shop for labs that will give them favorable test results.

    Read more »

  • The Cannabis Regulation Crossroads in Massachusetts

    The first five years of recreational Cannabis regulation in Massachusetts revealed a handful of problems. The industry is not diverse and equitable, and cities and towns have unethically taken advantage of the regulatory leverage they can hold over marijuana businesses. The state expects to reopen its regulations for additions, subtractions and revisions sometime later this year, as the industry has many wrongs to right.

    Read more »

  • Minnesota Legalizes Adult-Use Recreational Cannabis

    The new law modifies Minnesota’s list of controlled substances to exclude “industrial hemp” products that contain no more than 0.3% of any form of THC. That change brought Minnesota law in line with federal law. However, the law also allows Minnesota businesses to sell edible and drinkable products containing no more than five milligrams of THC per serving and no more than 50 milligrams of THC per package to people ages 21 and older.

    Read more »

  • New York Regulators Approve Adult-Use Cannabis Testing Regulations

    The approved interim regulations for New York’s Cannabis testing labs will ensure adult-use Cannabis products are not contaminated with pesticides, heavy metals or other adulterations. The rules will allow medical Cannabis testing labs to expand their operations to serve the adult-use market as well.

    Read more »

  • South Dakota Adds New Standards for Testing Medical Cannabis

    The effect of the rules will be to add regulations on testing of medical cannabis, including creation of batches and collection of samples. Under the rules, Cannabis testing labs must also update the inventory tracking system daily with all samples collected and the results of all tests performed.

    Read more »

  • Why Utah Isn’t Testing Medical Marijuana

    For over a year, Utah has not been pathogen testing medical marijuana for the typically tested for pathogenic bacteria. Last April, the Utah Department of Agriculture and Food suspended the requirement for pathogen-specific testing.

    The short answer: due to an equipment shortage, the state said it suspended Cannabis lab testing for E.coli, salmonella and several kinds of molds that cause illness, especially among the immunocompromised.

    Read more »

  • California to Standardize Cannabis Lab Testing to Stop ‘Laboratory Shopping’

    The California Department of Cannabis Control announced plans to standardize Cannabis lab testing methods amid concerns about exaggerated potency and “lab shopping” by businesses. Somewhat troubling, the department reports marijuana businesses are choosing labs that report higher THC levels than what is actually contained in the Cannabis. At PathogenDx, we stress that accurate and honest Cannabis pathogen testing is good for the future of the industry.

    Read article »

  • Connecticut Lawmakers Approve New Medical Cannabis Testing Regulations

    A legislative committee in Connecticut signed off on new medical Cannabis testing regulations that were proposed by regulators earlier this year. The new rules would set new allowable levels Total Yeast and Mold at a limit of 100,000 colony forming units per gram and would not allow any detectable levels of Aspergillus.

    Read full more »

  • More Stringent Cannabis Lab Testing Needed in the Industry

    With the increasing demand for legal Cannabis and heightened participation of various states, the need for comprehensive and rigorous Cannabis bacteria testing solutions has now become vital. Considering a lot of individuals use Cannabis products for medical purposes, they should have to worry about falling ill from consuming pathogenic bacteria infested Cannabis products. While there could be federal criteria for Cannabis pathogen testing prerequisite, that can’t happen just yet as cannabis isn’t legal at the federal level.

    Read full article »